About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Portland | 278 Studies

Clinical Trials Prostate CancerPortland

Prostate Cancer Clinical Trials in Portland

Find 278 clinical trials for prostate cancer near Portland, Oregon. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Portland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 278 trials

Active not recruitingTesting the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean StudyThis phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with…NCT05053152·Phoenix, Arizona and 244 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedTo Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) AntigenThis is a randomized, multicenter, single blind, Phase 2 trial of immunotherapy in men with metastatic androgen independent prostate cancer to evaluate sipuleucel-T manufactured…NCT00715078·La Jolla, California and 11 others

RecruitingTesting Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerThis phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45…NCT05946213·Birmingham, Alabama and 412 others

CompletedA Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerThe purpose of this study is to further quantify the risk of cerebrovascular events (CVEs) following sipuleucel-T (PROVENGE®) therapy, and to follow all subjects for survival.NCT01306890·Bessemer, Alabama and 332 others

CompletedRandomized Salvage Radiation Therapy Plus Enzalutamide Post ProstatectomyThe primary hypothesis of this study is that outcomes for patients with biochemically recurrent prostate cancer following radical prostatectomy will be improved by the addition of…NCT02203695·Washington D.C., District of Columbia and 8 others

Approved for marketingExpanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate CancerThis study provides expanded access to radiotracer Gallium 68 (68Ga)-prostate-specific membrane antigen (PSMA)-HBED-CC (68Ga-PSMA-11) with Positron Emission Tomography (PET)…NCT04452136·Portland, Oregon

Active not recruitingFPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)This is an open-label, randomized, multicenter study of FPI-2265 (225Ac-PSMA-I\&T).NCT06402331·Duarte, California and 17 others

RecruitingA Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate CancerThe main purpose of the study is to assess the safety and tolerability of AZD2284, AZD2287, and AZD2275.NCT06879041·Palo Alto, California and 15 others

RecruitingA Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)The purpose of this study is to evaluate the overall survival (length of time from the start of study to date of death from any cause) for pasritamig (JNJ-78278343) in Part 1 in…NCT07164443·La Jolla, California and 173 others

Active not recruitingPembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate CancerEligible patients will be treated with the combination of lenvatinib and pembrolizumab.NCT04848337·Duarte, California and 4 others

UnknownProstate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Androgens can cause the growth of prostate cancer cells.NCT00567580·Birmingham, Alabama and 459 others

Active not recruitingAn International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617 in combination with Standard of Care (SOC), versus Standard of Care alone, in adult male…NCT04720157·Scottsdale, Arizona and 166 others

CompletedA Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersThis is a study of CDX-1127, a therapy that targets the immune system and may act to promote anti-cancer effects.NCT01460134·Scottsdale, Arizona and 9 others

UnknownFecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.All patients will be required to have a biopsy of a metastatic tumor deposit at study entry.NCT04116775·Portland, Oregon

RecruitingPrecision-Based Genomics in Prostate CancerBackground: Prostate cancer is the most common cancer and the second leading cause of death in males in the United States.NCT04706663·La Jolla, California and 10 others

Active not recruitingRandomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate cancer.NCT02768363·Golden, Colorado and 22 others

CompletedBrachytherapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy through seeds implanted into the prostate may kill more tumor cells.NCT00003312·Birmingham, Alabama and 257 others

CompletedHormone Therapy Plus Chemotherapy in Treating Patients With Prostate CancerRATIONALE: Androgens can stimulate the growth of prostate cancer cells.NCT00030654·Phoenix, Arizona and 77 others

CompletedA Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate CancerThis is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of study entry.NCT03009981·Phoenix, Arizona and 68 others

TerminatedEPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPCThis is a Phase 1/2 study of EPI-7386 orally administered in combination with enzalutamide in subjects with mCRPC.NCT05075577·Tucson, Arizona and 23 others

Page 1 of 14Next

Other Conditions in Portland

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma